Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276081 · ClinicalTrials.gov registry record · Phase 4
Gabapentin Versus Estrogen for the Treatment of Hot Flashes
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00276081 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 60 participants.
The verdict
NCT00276081, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
To compare the efficacy and safety of gabapentin, estrogen and placebo in the treatment of hot flashes and other climacteric symptoms.
Interventions
- DRUG Gabapentin, Estrogen and placebo administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-05 |
| Est. Completion | 2004-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276081
The ClinicalTrials.gov registry entry for NCT00276081 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabapentin, Estrogen and placebo administration is the first listed.
NCT00276081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276081 about?
NCT00276081 is a clinical study titled "Gabapentin Versus Estrogen for the Treatment of Hot Flashes". To compare the efficacy and safety of gabapentin, estrogen and placebo in the treatment of hot flashes and other climacteric symptoms.
What is the current status of trial NCT00276081?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2002-05. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00276081?
The interventions under investigation include: Gabapentin, Estrogen and placebo administration (DRUG).
Who is sponsoring clinical trial NCT00276081?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.